<PAGE>
THIS DOCUMENT IS A COPY OF THE SCHEDULE 13G FILED ON FEBRUARY 14, 1997,
PURSUANT TO A RULE 201 TEMPORARY HARDSHIP EXEMPTION.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13D-1 AND 13D-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )1
Advanced Health Corporation
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
00756H 10 8
-------------------------------------------------
(CUSIP Number)
1The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP NO. 00756H 10 8 13G PAGE 2 OF 4 PAGES
------------- --- ---
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Jonathan Edelson, M.D.
SS#: ###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
462,149
NUMBER OF ---------------------------------------------------------
SHARES BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY N/A
EACH ---------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 462,149
WITH ---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
N/A
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
462,149
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.3%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Item 1.
(a) This Statement relates to the securities of Advanced Health
Corporation, a Delaware corporation (the "Issuer").
(b) The principal executive offices of the Issuer are located at 560
White Plains Road, Tarrytown, New York 10591.
Item 2.
(a) The name of the person filing this statement is Jonathan Edelson,
M.D.
(b) The principal business address of the person filing this
statement is 560 White Plains Road, Tarrytown, New York 10591.
(c) The person filing this Statement is a citizen of the United
States of America.
(d) This statement relates to the Common Stock $.01, par value (the
"Common Stock"), of the Issuer.
Item 3.
(a) Not applicable
Item 4.
(a) On December 31, 1996, Jonathan Edelson, M.D. beneficially owned
462,149 shares of Common Stock (including options to purchase 201,286
shares of Common Stock).
(b) The Common Stock of the person filing this statement represent
6.3% of the Common Stock issued and outstanding on December 31, 1996.
(c) The person filing the statement has sole voting and dispositive
power regarding the 462,149 shares of Common Stock.
Item 5.
(a) Not applicable.
Item 6.
(a) Not applicable.
Item 7.
(a) Not applicable.
Item 8.
(a) Not applicable.
Item 9.
(a) Not applicable.
Item 10.
(a) Not applicable.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 14, 1997
/s/ Jonathan Edelson, M.D.
-----------------------------------
Jonathan Edelson, M.D.